We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Editas Medicine
EDIT
$445M
| $785K | 0.08% |
+32,100
| New | +$727K |
|
427
Sally Beauty Holdings
SBH
$1.51B
| $783K | 0.08% |
42,534
-47,062
| -53% | -$841K |
|
|
AXE
428
DELISTED
Anixter International Inc
AXE
| $783K | 0.08% |
13,946
+9,922
| +247% | +$580K |
|
429
Kohl's
KSS
$2.09B
| $782K | 0.08% |
11,369
-9,278
| -45% | -$629K |
|
430
Occidental Petroleum
OXY
$55.7B
| $781K | 0.08% |
+11,791
| New | +$777K |
|
431
Iron Mountain
IRM
$36.3B
| $778K | 0.08% |
+21,940
| New | +$775K |
|
432
First Hawaiian
FHB
$3.35B
| $777K | 0.08% |
29,839
+17,778
| +147% | +$460K |
|
433
The Bancorp
TBBK
$2.95B
| $777K | 0.08% |
96,182
-11,196
| -10% | -$96.8K |
|
|
ZAYO
434
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $777K | 0.08% |
27,332
+15,156
| +124% | +$402K |
|
435
Harvard Bioscience
HBIO
$27.9M
| $776K | 0.08% |
18,016
-1,150
| -6% | -$41.7K |
|
436
Haemonetics
HAE
$3.86B
| $775K | 0.08% |
8,856
-5,889
| -40% | -$536K |
|
|
PRFT
437
DELISTED
Perficient Inc
PRFT
| $775K | 0.08% |
+28,298
| New | +$745K |
|
438
Vertex Pharmaceuticals
VRTX
$123B
| $772K | 0.08% |
4,195
-417
| -9% | -$77K |
|
|
TUP
439
DELISTED
Tupperware Brands Corporation
TUP
| $771K | 0.08% |
30,132
+2,299
| +8% | +$70.2K |
|
440
Qualys
QLYS
$6.29B
| $770K | 0.08% |
9,303
-5,258
| -36% | -$438K |
|
|
XOMA
441
DELISTED
Xoma
XOMA
| $770K | 0.08% |
62,177
+4,762
| +8% | +$65.1K |
|
442
Sherwin-Williams
SHW
$88.2B
| $768K | 0.08% |
+5,346
| New | +$744K |
|
443
NCR Voyix
VYX
$1.15B
| $768K | 0.08% |
+45,867
| New | +$760K |
|
444
Urban Outfitters
URBN
$6.65B
| $766K | 0.08% |
25,851
+6,110
| +31% | +$188K |
|
445
Travel + Leisure Co
TNL
$4.74B
| $764K | 0.08% |
+18,864
| New | +$794K |
|
446
Ametek
AME
$57.6B
| $763K | 0.08% |
9,194
+3,718
| +68% | +$283K |
|
|
QVCGA
447
DELISTED
QVC Group Inc Series A
QVCGA
| $763K | 0.08% |
+983
| New | +$948K |
|
448
Integer Holdings
ITGR
$4.29B
| $762K | 0.08% |
+10,107
| New | +$827K |
|
449
Williams-Sonoma
WSM
$29.1B
| $760K | 0.08% |
+27,024
| New | +$746K |
|
450
Cincinnati Financial
CINF
$27.5B
| $757K | 0.08% |
+8,807
| New | +$727K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.